Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 192.60 2.53
Larsen & 1524.40 7.32
Sslt 291.60 0.45
Bharti A 373.00 5.26
Tata Stl 544.90 0.48
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Lifeline Drugs & Pharma Limited
Lifeline Drugs & Pharma Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:506113NSE:NABloomberg:LDPL@INReuters:LIFE.BO
Market Lot: 1Face Value: 1ISIN Demat: INE776N01028
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
27-SEP-13 Lifeline Drugs & Pharma said on Thursday its board of directors will meet on October 01, 2013 to consider splitting, sub-division of face value of equity shares. 26-SEP-13 Lifeline Drugs & Pharma said that its board of directors will meet on Oct. 01, 2013, to consider split/sub-division of face value of shares. Future Plans The company is expected to set up a greenfield project for manufacturing bulk drugs and intermediates and ...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
  -
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2014(12)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 400.780.000.00
Other Income7.682.861.35
Total Income408.462.861.35
Cost of goods sold398.680.820.84
OPBDIT9.782.040.51
PAT6.561.410.51
Gross Block---
Equity capital36.2430.742.40
EPS (Rs.)-0.462.12
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-18.48 - 74.7819.20 - 19.20
Debt / Equity (x)---
Operating margin (% of OI) 2.471.337.8
Net margin (% of OI) 1.649.337.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
Not Available
 
Board of Directors
Board Meetings
Date Purpose
14-AUG-14 Quarterly Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer